Eformoterol
RxNorm 25255
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 25255 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Eformoterol.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Eformoterol
(Atom ID: 2064265)
INPrescribable
Ingredient (IN):
Formoterol
(Atom ID: 416604)
PTPrescribable
Designated preferred name (PT):
Formoterol
(Atom ID: 2064564)
FNPrescribable
Full form of descriptor (FN):
Formoterol (substance)
(Atom ID: 2064565)
PTPrescribable
Designated preferred name (PT):
Formoterol-containing product
(Atom ID: 10803302)
FNPrescribable
Full form of descriptor (FN):
Product containing formoterol (medicinal product)
(Atom ID: 9724379)
Patient Education
Formoterol Oral Inhalation
Formoterol oral inhalation is used to control wheezing, shortness of breath, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of lung diseases that includes chronic bronchitis and emphysema). Formoterol is in a class of medications called long-acting beta agonists (LABAs). It works by relaxing and opening air passages in the lungs, making it easier to breathe.
[Learn More]
* Please review the disclaimer below.